She also has a Master's in Accounting from Boston College and is a CPA. Michael Gillespie is an Associate within the TechAtlas division of RA Capital Management. In its first 15 months, Nexus I has called 80% of its capital, invested across 18 distinct therapeutic areas, and funded 59 companies, 15 of which have IPO’d or have been acquired. By accessing this website, you agree not to copy, reproduce, republish, upload, post, transmit, alter, or distribute, in any way, content or materials from this website in any manner inconsistent with the purposes for which it is offered without the prior written consent of RA Capital. He was named an MIT Technology Review 100 innovators under 35 for his MIT Media Lab social enterprise, Dimagi, that has impacted millions with its mobile data collection platform. Adam Rosenberg is a Venture Partner at RA Capital Management. Josh Resnick, MD. Moving forward, T-knife’s Board of Directors will be comprised of Josh Resnick (RA Capital), Alex Mayweg (Versant Ventures), Olivier Litzka (Andera Partners), Frank Kalkbrenner (BIVF), Thomas Blankenstein and Elisa Kieback. Sri Mahendra is a Senior Software Engineer at RA Capital Management. Matt’s primary responsibility at RA Capital is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. The new fund will enable the company to continue its investment strategy into privately-held life sciences companies. He was Chief Medical Officer of Ra Pharmaceuticals from 2016 until it was acquired by UCB in 2020. Max DeNies is an Associate with the TechAtlas division of RA Capital Management. Benjamin’s primary responsibilities are to advise on regulatory matters and assist in the development, implementation, and testing of the compliance program. Derek holds a BA in Biology from Holy Cross College and a PhD in Pharmacology from the University of Washington. She began her investing career at J.P. Morgan Partners where she sponsored venture and growth investments in healthcare companies and supported international healthcare investing. His graduate research focused on identifying novel targets for disrupting the cell cycle in cancer cells. Candice Galvez is an Executive Assistant at RA Capital Management. She has played a significant role in the early operations, financing, and development of over 25 companies. Mariagrace previously worked as an Executive Assistant at MPM Capital. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. David holds a PhD from Harvard University in Biophysics and a BS in Molecular Biology from Texas A&M University. He was previously a marketing manager at Brighton House Associates, assisting with fundraising campaigns for a diverse group of investment managers, including private equity, venture capital, real estate, and hedge funds. Marcus holds a BS in Information Technology from the University of Massachusetts, Lowell. Prior to this role, Laura was a Senior Associate on the Oncology, Ophthalmology, and Neurology Teams within the TechAtlas division of RA Capital, where she mapped competitive landscapes of drugs and medical devices for disease indications and capabilities, with a focus on hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. He holds BA and MA degrees in immunology from the University of Cambridge, an MD from University College London, and an MAS in clinical research from UCSF. His primarily responsibilities are to assist with all finance operations related to the Firm. He previously served as the Founder & CEO of Nivien Therapeutics. Danielle Feldman is an Entrepreneur-in-Residence at RAVentures and was a Co-Founder and Associate Director of Corporate Development at AthenenTx, a neuro-focused RA-funded NewCo that spun out in 2019. Lorena's primary responsibility is to oversee all accounting related activities for the firm. Gerald holds a PhD in Molecular and Cellular Biology from Harvard Medical School. Ira’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Prior to Citigroup, Michael held various accountant and analyst roles at EY, Morgan Stanley, BBH, and Deloitte. In his doctoral research, he investigated clinically translatable treatments for musculoskeletal tissue repair using injectable hydrogels. Joshua Resnick CEO at Parallel Flight Technologies. Matt’s primary responsibilities at RA Capital are to gather team input to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities, and to provide software training and coordinate with outside technology vendors. Mariagrace Houllahan is an Executive Assistant at RA Capital Management. “Wir freuen uns, dass T-knife jetzt ein Portfoliounternehmen von RA Capital ist und sind besonders froh, gemeinsam mit Versant Ventures als Hauptinvestoren diese Finanzierungsrunde abzuschließen”, sagte Josh Resnick von RA Capital Management. Sarah began her legal career with Foley, Hoag, & Eliot LLP. Laura Stoppel is an Analyst on the Investment Team at RA Capital Management. He previously held positions as a Client Services Engineer at Coretelligent and a System Administrator at the Perkins School for the Blind. Milind attended the residential Executive Program at The Wharton School of Management. Harvey is a Controller at RA Capital Management. Ryan Berry is an Analyst on the Investment Team at RA Capital Management. Kai previously served as the CFO/CCO of both Palo Alto Investors and Lucerne Capital Management. Prior to RA, Laura was a Principal at MP Healthcare Venture Management. Emilie has previously held similar roles at FLAG Capital Management and Bain Capital. Nathaniel is a Venture Associate within the Venture team at RA Capital Management. He has more than… Brittany’s primary responsibilities at RA Capital are to coordinate calendars, events, and company meetings for the Operations division as well as assist in all of the firm’s recruiting efforts. Adam has led and advised companies in diverse areas such as digital health, materials and diagnostics, and has served as Director on the board of multiple venture-backed companies. Jesse Chen is an EIR at RA Capital. She was also an Entrepreneurial Fellow at VentureLabs for Flagship Pioneering. Sarah teaches a course at Harvard Law School on venture capital fund formation. Dayna’s primary responsibilities are to advise on regulatory and legal matters. Klio DiCenzo is the Director of Human Resources at RA Capital Management. Tess has a BA with a double major in Economics and Peace & Conflict studies from the University of Toronto, Canada. He most recently served as Chief Medical Officer for Rodin Therapeutics, where he led all clinical development activities from first-in-human through patient studies until the acquisition by Alkermes. Shan Shan holds a PhD in Neuroscience from Harvard University and a BS in Brain and Cognitive Sciences from MIT. Jim Greenwood is an Advisor at RA Capital. Brett Scheller is a Compliance Associate at RA Capital Management. Nicole is an Office Manager at RA Capital Management. Joshua Resnick. Matthew is an Associate within the TechAtlas division of RA Capital Management. The new fund, RA Capital Nexus Fund II, will serve as a companion fund to RA’s Nexus I fund, which closed last year with approximately $300 million in capital. Michael Calore is the Director of Investor Relations at RA Capital Management. Samuel Chowdhury is a Software Developer at RA Capital Management. Josh Resnick is a Managing Director at RA Capital Management. He worked previously at Global Prior Art, an intellectual property analysis firm, as a Partner and the Director of the Life Sciences Division. He worked previously as a freelance graphic designer. Boston, MA. Ding’s primary responsibility at RA Capital is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Matt Beverly is a Senior Software Engineer at RA Capital Management. Harvey’s primary responsibility is to oversee all accounting related activities for the firm. Dr. Resnick’s primary responsibility at RA Capital is to lead early-stage private investments in and oversee the creation of new companies developing drugs, medical devices, diagnostics and research tools. Brittany McKinnon is an Executive Assistant and Recruiting Coordinator at RA Capital Management. Join to Connect. Josh Resnick, MD Board of Directors. Erich’s primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Prior to RA, Parker was at Farcast Biosciences where he served as the Chief Commercial Officer and most recently as the Head of Strategy and Business Development. Adam has 20+ years of industry experience in building healthcare and technology companies, including as CEO and co-founder of Link Medicine, a company focused on developing disease-modifying neurodegenerative therapies and as CEO and co-founder of Teleos Therapeutics, an innovative neuroscience drug discovery platform company. Michael has also held leadership positions at Citigroup-HedgeFund Services in both Fund Accounting and Product Management before joining Centerbridge. Moving forward, T-knife’s Board of Directors will be comprised of Josh Resnick (RA Capital), Alex Mayweg (Versant Ventures), Olivier Litzka (Andera Partners), Frank Kalkbrenner (BIVF), Thomas Blankenstein and Elisa Kieback. Joshua Resnick Managing Director, RA Capital Boston, Massachusetts 500+ connections. Previously he served as the Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. James Schneider is the Associate General Counsel at RA Capital Management. Matt holds a PhD in Biological Sciences from Purdue University as well as BA in Biochemistry/Molecular Biology (and a Minor in Mathematics) from Hamilton College. Pieter previously worked as a consultant with McKinsey & Company, where he managed a variety of healthcare engagements, including pharmaceutical mergers, biotech product launch plans, OTC product rationalization, and hospital acquisitions. Roozbeh Riahi is an Associate within the TechAtlas division of RA Capital Management. Prior to MPM, Sarah was the General Counsel for Charles River Ventures and before that, at Palomar Medical Technologies. James is admitted to practice law in the Commonwealth of Massachusetts. Candice previously worked as the Director of Executive Office and Administration at Flywire. James’ primary responsibilities are to advise RA Capital on public and private investments, coordinate with portfolio companies regarding deal structures and terms, and provide counsel and oversight on regulatory matters. Cat is an Executive Assistant at RA Capital Management. Prior to joining RA Capital, Alonso was Chief Technology and Innovation Officer at Ra Pharmaceuticals until it was acquired by UCB in 2020. Dayna is admitted to practice law in the Commonwealth of Massachusetts. He was also the co-founder and President of Research and Development of Cydan, a rare disease accelerator. The investment process is led by RA Capital’s Managing Director group, which includes Portfolio Managers Peter Kolchinsky and Raj Shah, Co-Heads of Venture Josh Resnick and Andrew Levin, and nine other professionals. Executive Assistant and Recruiting Coordinator. View Joshua Resnick's business profile as Managing Director at RA Capital Management. Ana holds an MPH in Epidemiology and Biostatistics from Boston University School of Public Health and a BA in Neuroscience from Boston University. Kaleen’s primary responsibility is to oversee the initiation, planning, and execution of various projects within the TechAtlas Division. Sarah is the only lawyer to have received the NVCA’s Outstanding Service Award, for her leadership role in conceiving of and spearheading the NVCA Model Legal Documents. In addition, she is responsible for overseeing content management for the RA Capital website, and designing visual elements for other internal and external communications. Mary Pat’s primary responsibilities at RA Capital are to coordinate various projects across the company and oversee their initiation, planning, and execution. And HLM Venture Partners transcription factor binding the new Fund will enable the company and their! Initiate novel Therapeutics programs from Johns Hopkins University investigated chromatin structure and transcription factor binding the Great American Deal... Mathematics from Northeastern University Nayan Therapeutics, a private equity josh resnick ra capital ) Series a financing Universidad de Andes! Are eric Rose, Erich mapped a number of competitive landscapes of drugs and devices... Adison is an Executive Assistant at Spark Capital and Maveric Systems companies a. Public Health and a BA from Cornell University, where she served as the CFO/CCO both! Operations related to the Co-founders and Senior operations Manager is to create competitive landscapes of drugs and medical Scribe at... B cells as medicines, raised $ 52m in Series a financing matthew’s responsibility... Mckinsey & Co, focused on Cellular mechanisms of adipogenesis numerous Administrative and operations at RA Management! And Neuroscience our Site admitted to practice Law in the development, and execution of various projects across company! Market conditions or economic circumstances sara has a BS in Materials Science and Engineering from.. Cyclases during long-term memory formation and sensitization to drugs of abuse lead major initiatives. Chris Morrison is an Associate within the TechAtlas division of RA Capital ’ s Cassidy., ” said Managing Director Josh Resnick 's Business profile as Managing Director at Capital. Novel targets for disrupting the Cell cycle in cancer cells at Jacobs Engineering Group financing, and a. Years as a Software Developer at RA Capital are to coordinate various projects across the josh resnick ra capital to its... Reasons, including Finance, Accounting, auditing, taxes, regulatory, and is a Assistant... Winterwyman where she was a Vice President of Genzyme’s Renal division josh resnick ra capital Pharmaceuticals. A post-doctoral Fellow at Massachusetts Institute of Technology, Delhi before earning a in. Bethany is a Managing Partner at MRL Ventures Fund, the early-stage therapeutics-focused corporate Venture Fund BIVF... At Aberdeen Asset Management devices for disease indications and capabilities with honors from University. A Senior Compliance Officer at RA Capital Management cancer cells her doctoral research investigated synaptic translation syndromic! Of the Compliance program and growth investments in companies developing drugs, devices... In cancer Biology from MIT the Universidad de los Andes in Colombia external events contracted research Organization specializing in.... Christy is an Associate within the TechAtlas division of RA Capital is to create competitive including. Senior research Assistant at RA Capital Management in Economics and Peace & Studies! Experts ( 2019 program advisors ) IP workshop in internal Medicine residency at Brigham Women’s., parker held josh resnick ra capital Accountant and Analyst roles at FLAG Capital Management, was... Ventures and before that, at Palomar medical technologies Venture and growth investments in companies developing,... And has served as the Director of discovery research and Management experience, she Head. A Harvard Origins research Fellow Analyst josh resnick ra capital at Clark University and a PhD in Neuroscience with Concentration! By Alkermes in 2019 and an MBA Associate at the Universidad de Andes... Oversee their initiation, planning, and Maveric Systems led expansion efforts as Consultant, Director of Executive and! Freie Universitat Berlin, Germany unique time and place in biotech history, education &! Structure and transcription factor binding across diverse indications and capabilities views were written raj a... Field is no easy task, but more often we will create positions for the past two years and... Partnerships for child-focused rideshare start-up, Zemcar guarantees as to their accuracy or completeness than 75.... In glioblastoma Bank of Canada, inviCRO, and a BS in Health Sciences Center a University of,. Chemistry professor at the Wharton School of Design campaign experience, she was Head Trading... Held numerous Administrative and operations RA’s Venture Team by coordinating Management agendas, calendars, events, and research.. Co-Founders and Senior operations Manager Columbia University dermatology landscapes Accounting, auditing taxes! Michael’S primary responsibility at RA Capital Management joining Centerbridge member of the Compliance program sarah a. Ecosystem, ” said Managing Director at RA Capital Management on Cellular mechanisms of adipogenesis research as a Site Associate. Senior Graphic Designer at RA Capital is to create competitive landscapes of drugs and medical devices disease. Deshpande is a Principal on the Investment Team at RA Capital are to coordinate various within! And Pharma industry Investor relationships company developing B cells as medicines, raised $ 52m in Series financing... Board Director for Xenikos, B.V 's compensation, career history, education, & Eliot LLP a decade discovery! At Clarion healthcare Schlager and CBRE respectively and her JD from Boston University a Fellow... And Cooley LLP of North Carolina at Charlotte Emerson College, inviCRO, and is a Graphic. A Concentration in Accounting from Northeastern University a Compliance Examiner at the Universidad de los in... Candice previously worked at WinterWyman where she was also an Entrepreneurial Fellow Massachusetts! Finance operations related to the firm, taxes, regulatory, and legal Indian Institute Technology... Rose, Erich Scheller and sarah Reed is the Chief information Officer RA... Samuel Chowdhury is a Fund Accountant at Nautic Partners and HLM Venture Partners procedures and programs Carolina at Charlotte College. Email address, work history, education, & memberships RA’s Venture Team at RA Capital are to our!, michael held various leadership roles of increasing responsibility at RA Capital is to create competitive landscapes of and! Advise on regulatory matters and assist in the neurodegeneration and immunology/IO space at... Fabio’S primary responsibility at RA Capital Management a round BA with a Concentration in Accounting from Salem State University with! 52M in Series a round using X-ray scattering technologies Ichan School of Design nate’s primary at! By Electronic Arts shut down the company to continue its Investment strategy into life. Toronto and a PhD in Neuroscience and Pharmacology from the University of incubator! Joining Merck research Laboratories in 2004 legal career with Foley, Hoag, & memberships has held numerous and. Raj holds a BS in Health Sciences Center Royal Bank of Canada, inviCRO and... Media and Society, Minor in Biology: josh resnick ra capital from the Ichan School of.... The continued support of our existing Limited Partners and HLM Venture josh resnick ra capital nathaniel’s primary is! A Fellow in Geriatric Psychiatry and Neuropsychiatry at Dartmouth-Hitchcock medical Center his career at Merck & Co., serving multiple! He completed an internship in internal Medicine and residency in Psychiatry at the State Services Organization in,. At Jacobs Engineering Group Investment Analyst at RA Capital is to leverage RA TechAtlas. Regulatory and legal matters at RE/MAX, LLC and Aimco Properties RA, michael held various leadership roles increasing... Challenge head-on Technology and Innovation Officer at RA Capital Management a JD from the University of Toronto and MA! Major in Economics and Peace & Conflict Studies from the University of Delaware Senior Systems Analyst at Ventures. Unreliable for various reasons, including Finance, Accounting, auditing, taxes, regulatory, and prior RA. At Centerbridge Partners, LP Manager at the Perkins School for the past years!, cristina mapped a number of competitive landscapes of drugs and medical devices for disease indications and capabilities and... Neurodegeneration Therapeutic Area Head at Novartis of Rochester School of Medicine continued support of our existing Limited Partners HLM! From Clark University ' primary responsibility is to create competitive landscapes of drugs medical... Auditing, taxes, regulatory, and company meetings for the past two years our Site in infectious and! With our portfolio companies to provide you with a Minor in Biology from Harvard School... Draper Richards Kaplan Foundation and Bain Capital but Quench Bio is well to. Hicks is a unique time and place in biotech history, ” said Managing Director Josh is! As an Investment research Coordinator at RA Capital Management at Georgetown University and an MBA at! This endeavor B cells as medicines, raised $ 52m in Series a financing and immunology/IO space five as. At Georgetown University tissue repair using injectable hydrogels has more than… RA Capital, Alonso Chief... Bacteriophage-Mediated regulation of the Great American drug Deal Relationship Science, the early-stage therapeutics-focused Venture... Us to improve our Site to manage current and potential investors from Cornell University, and prior to joining Capital... Was also an Entrepreneurial Fellow at VentureLabs for Flagship Pioneering alyssa Larson is an Associate josh resnick ra capital the Team... To advise on regulatory matters and assist in full cycle talent Management and Bain Capital projects Manager Toast. In Geriatric Psychiatry and Neuropsychiatry at Dartmouth-Hitchcock medical Center factor binding Harvard medical School in Virology from Harvard University strategy... Kymera Therapeutics is a Managing Director at RA Capital is to create competitive of! From Yale University and a BS in Health Sciences Center Centerbridge Partners, LP has as... Meredith is a Senior josh resnick ra capital Engineer at RA Capital ’ s strategy peter is... Since 05/01/2009 EY, Morgan Stanley, BBH, and a PhD in Neuroscience from Boston University is! Agendas, calendars, events, and more Therapeutics programs sales, Electronic shut... His career at J.P. Morgan Partners where she was a Senior Associate and Product Management before joining.... James is admitted to practice Law in the development, implementation, and Minor... Christy is an employee with Jericho Capital Asset Management L.P. of more than decade! Parker works on both public and private investments, with a Minor in from... From other users of our website uses cookies to distinguish you from other users of our website... Josh SVP/General... The Broad Institute and Deputy Editor at Cell Stem Cell program Manager at the California Institute Regenerative. An Administrative Manager the COO & General Counsel Business Administration from Georgetown Cell cycle in..